Kiora Pharmaceuticals Reports Additional Clinical Data for KIO-301 Showing a Statistically Significant Increase in Brain Activity in the Visual Cortex in Patients with Retinitis Pigmentosa
Go back to Kiora Pharmaceuticals Reports Additional Clinical Data for KIO-301 Showing a Statistically Significant Increase in Brain Activity in the Visual Cortex in Patients with Retinitis Pigmentosa| (NASDAQ: KPRX) | Delayed: 2.60 +0.01 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.59 | 52 Week High | $ | |||
| Open | $2.57 | 52 Week Low | $ | |||
| Day High | $2.68 | P/E | N/A | |||
| Day Low | $2.52 | EPS | $ | |||
| Volume | 34,321 | |||||
